companies / auragentbio-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-05 json
| total_raised | 2,000,0002.0M (derived) | derived |
|---|---|---|
| founded | 2015 | |
| hq | Chesterfield, Missouri, USA | |
| industry | unknown | |
| stage | null |
Develops infectious-disease therapeutics from microbial natural-product chemistry, with programs in antibacterials and antifungals. Targets pharma partners and biosecurity funders concerned with multi-drug-resistant pathogens. Spun out of academic natural-product chemistry research in St. Louis with a focus on novel scaffolds rather than analog programs.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-09-01 | grant | 2,000,0002.0M | null | ○ |
Google Analytics G-?GA4:, Firebase, Next.js
| fact | status | src |
|---|---|---|
| Grant, $2.0M | attributed | ○ |
| total | derived: Stated total is below the largest recorded round; sum of recorded rounds used | derived |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-28provenance_total: unknown → derived, derived 2026-05-05 | provenance_total | unknown → derived | derived 2026-05-05 |
| 2026-09-28total_raised: 1968696 → 2000000, derived 2026-05-05 | total_raised | 1968696 → 2000000 | derived 2026-05-05 |
Records begin 2026-09-24. all_changes